An unconventional FDA panel is assessing the safety and efficacy of previously-banned peptides. It could open up a multibillion-dollar market.
Source: [Business Insider](https://www.businessinsider.com/rfk-convenes-unusual-fda-panel-to-assess-peptide-safety-issues-2026-7)